Have a personal or library account? Click to login
A Scoping Review of Clinical Guidelines for the Management of Cardiovascular Diseases (CVD) in Pregnancy in Low- and Middle-Income Countries (LMIC) Cover

A Scoping Review of Clinical Guidelines for the Management of Cardiovascular Diseases (CVD) in Pregnancy in Low- and Middle-Income Countries (LMIC)

Global Heart
Volume 20 (2025): Issue 1
By: Uma Vasudevan,  Preety Rajbangshi and  Jane Hirst  
Open Access
|Aug 2025

References

  1. 1World Health Organization. World Health Organization; 2023 [cited 2023 Nov 16]. Maternal mortality. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality
    Back to article
  2. 2Nair M, Nelson-Piercy C, Knight M. Indirect maternal deaths: UK and global perspectives. Obstetric Medicine. 2017;10(1):10–15. DOI: 10.1177/1753495X16689444
    Back to article
  3. 3Storm F, Agampodi S, Eddleston M, Sørensen JB, Konradsen F, Rheinländer T. Indirect causes of maternal death. The Lancet Global Health. 2014;2(10):e566. DOI: 10.1016/S2214-109X(14)70297-9
    Back to article
  4. 4Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(34):3165–3241. DOI: 10.1093/eurheartj/ehy340
    Back to article
  5. 5Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Current Cardiology Report. 2017;19(10):96. DOI: 10.1007/s11886-017-0910-6
    Back to article
  6. 6Elkayam U, Goland S, Pieper PG, Silverside CK. High-risk cardiac disease in pregnancy: Part I. Journal of the American College of Cardiology. 2016;68(4):396–410. DOI: 10.1016/j.jacc.2016.05.048
    Back to article
  7. 7Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: The CARPREG II study. Journal of the American College of Cardiology. 2018;71(21):2419–2430. DOI: 10.1016/j.jacc.2018.02.076
    Back to article
  8. 8Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323–e333. DOI: 10.1016/S2214-109X(14)70227-X
    Back to article
  9. 9Keepanasseril A, Pfaller B, Metcalfe A, Siu SC, Davis MB, Silversides CK. Cardiovascular deaths in pregnancy: Growing concerns and preventive strategies. Canadian Journal of Cardiology. 2021;37(12): 1969–1978. DOI: 10.1016/j.cjca.2021.09.022
    Back to article
  10. 10Gad MM, Elgendy IY, Mahmoud AN, Saad AM, Isogai T, Sande Mathias I, et al. Disparities in cardiovascular disease outcomes among pregnant and post-partum women. Journal of the American Heart Association. 2020;10(1):e017832. DOI: 10.1161/JAHA.120.017832
    Back to article
  11. 11Shrestha P, Kuikel S, Bajracharya S, Ghimire A, Shrestha R, Mishra A, et al. Pregnancy with heart disease in South Asia: A systematic review and meta-analysis of prevalence and outcome. Annals of Medicine and Surgery (London). 2022;80:104293. DOI: 10.1016/j.amsu.2022.104293
    Back to article
  12. 12Lumsden R, Barasa F, Park LP, Ochieng CB, Alera JM, Millar HC, et al. High burden of cardiac disease in pregnancy at a national referral hospital in Western Kenya. Global Heart. 2020;15(1):10. DOI: 10.5334/gh.404
    Back to article
  13. 13Gupta N, Gupta S, Lalchandani A, Gupta R, Diwedi S, Singh J. Relationship of degree of anemia as direct or indirect causes of heart failure and its impact on maternal and fetal outcome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2014;3(4):982–985. DOI: 10.5455/2320-1770.ijrcog20141220
    Back to article
  14. 14Sliwa K, Böhm M. Incidence and prevalence of pregnancy-related heart disease. Cardiovascular Research. 2014;101(4):554–560. DOI: 10.1093/cvr/cvu012
    Back to article
  15. 15Khalid H, Karishma F, Mumtaz H, Saqib M, Iftikhar M, Shahab R. Current status and future of cardio-obstetrics-review. Annals of Medicine and Surgery (London). 2023;85(6):2774–2780. DOI: 10.1097/MS9.0000000000000773
    Back to article
  16. 16Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology. 2018;18(1):143. DOI: 10.1186/s12874-018-0611-x
    Back to article
  17. 17Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis [Internet]. JBI; 2024 [cited 2024 May 22]. Available from: https://jbi-global-wiki.refined.site/space/MANUAL/355862497/10.+Scoping+reviews
    Back to article
  18. 18The World Bank. The World Bank. 2022 [cited 2022 Dec 19]. World Bank Country and Lending Groups – World Bank Data Help Desk. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
    Back to article
  19. 19WHO. WHO recommendation on calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications [Internet]. World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240003118
    Back to article
  20. 20WHO. WHO recommendation on calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications [Internet]. World Health Organization; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/277235/9789241550451-eng.pdf?ua=1
    Back to article
  21. 21WHO. WHO recommendations on drug treatment for non-severe hypertension in pregnancy [Internet]. World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240008793
    Back to article
  22. 22WHO. WHO recommendations on drug treatment for severe hypertension in pregnancy [Internet]. World Health Organization; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/277234/9789241550437-eng.pdf?ua=1
    Back to article
  23. 23WHO. WHO recommendations on Policy of interventionist versus expectant management of severe pre-eclampsia before term [Internet]. World Health Organization; 2018. Available from: https://www.who.int/publications/i/item/9789241550444
    Back to article
  24. 24World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia [Internet]. World Health Organization; 2011 [cited 2023 Nov 7]. Available from: https://iris.who.int/handle/10665/44703
    Back to article
  25. 25World Health Organization. WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. World Health Organization; 2021.
    Back to article
  26. 26Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynaecology & Obstetrics. 2019;145(Suppl 1):1–33. DOI: 10.1002/ijgo.12802
    Back to article
  27. 27Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. DOI: 10.1161/HYPERTENSIONAHA.117.10803
    Back to article
  28. 28Ministry of Health Malaysia, Academy of Medicine Malaysia, National Heart Association of Malaysia. Clinical Practice Guideline Heart Disease in Pregnancy, 2nd edition [Internet]. Ministry of Health Malaysia; 2016. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/CPG/CARDIOVASCULAR/7.pdf
    Back to article
  29. 29Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. Hypertensive disorders in pregnancy: 2019 National guideline. South African Medical Journal. 2019;109(9). Available from: http://www.samj.org.za/index.php/samj/article/view/12723
    Back to article
  30. 30Grupo elaborador de la guía (GEG) – Dirección de Guías de Práctica Clínica, Farmacovigilancia y Tecnovigilancia del Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI), del Seguro Social de Salud (EsSalud) del Perú. Guía de práctica clínica para la prevención y el manejo de la enfermedad hipertensiva del embarazo. Revista Colombiana de Obstetricia Ginecologia. 2022;73(1):48–61. DOI: 10.18597/rcog.3810
    Back to article
  31. 31Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association. Diagnosis and treatment guideline of hypertensive disorders in pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi. 2015;50(10):721–728.
    Back to article
  32. 32Avila WS, Alexandre ERG, Castro ML de, Lucena AJG de, Marques-Santos C, Freire CMV, et al. Brazilian Cardiology Society statement for management of pregnancy and family planning in women with heart disease – 2020. Arquivos Brasileiros de Cardiologia. 2020;114(5):849–942. DOI: 10.36660/abc.20200406
    Back to article
  33. 33Baqai SM, Rahim R, Ala H, Tarar SH, Waqar F, Yasmeen H, et al. Society of Obstetricians and Gynaecologists Pakistan (SOGP) hypertensive disorders in pregnancy guidelines – 2022. Pakistan Armed Force Medical Journal. 2022;72(3):731–753. DOI: 10.51253/pafmj.v72i3.8600
    Back to article
  34. 34De Silva PHP, Lanerolle S, Dodampahala SH, Silva R, Mathota C. Hypertensive disorders of pregnancy. Sri Lanka Journal of Obstetrics and Gynaecology. 2022;44(1):65. DOI: 10.4038/sljog.v44i1.8046
    Back to article
  35. 35Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. Hypertensive disorders in pregnancy: 2019 National guideline. South African Medical Journal. 2019;109(9). Available from: http://www.samj.org.za/index.php/samj/article/view/12723
    Back to article
  36. 36Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Z✓hlke L, et al. Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa. Heart. 2014;100(24):1967–1974. DOI: 10.1136/heartjnl-2014-306199
    Back to article
  37. 37Soma-Pillay P, Seabe J, Soma-Pillay P, Seabe J, Sliwa K. The importance of cardiovascular pathology contributing to maternal death: Confidential Enquiry into Maternal Deaths in South Africa, 2011–2013. Cardiovascular Journal of Africa. 2016;27(2):60–65. DOI: 10.5830/CVJA-2016-008
    Back to article
  38. 38Rakisheva A, Sliwa K, Bauersachs J, Van Linthout S, Chopra VK, Bayes-Genis A, et al. Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC. European Journal of Heart Failure. 2024;26(4):742–753. DOI: 10.1002/ejhf.3246
    Back to article
  39. 39RHDAustralia (ARF/RHD writing group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Medical Journal of Australia. 2022;214(5):220–227. DOI: 10.5694/mja2.50851
    Back to article
  40. 40van der Graaf R, van der Zande ISE, den Ruijter HM, Oudijk MA, van Delden JJM, Oude Rengerink K, et al. Fair inclusion of pregnant women in clinical trials: An integrated scientific and ethical approach. Trials. 2018;19(1):78. DOI: 10.1186/s13063-017-2402-9
    Back to article
  41. 41Asalkar M, Shaikh H, Mahadik PV, Shaikh P, Pardeshi A, Wakte SP, et al. Inclusion of pregnant women in clinical trials: Need, ethical and scientific considerations and current status. Journal of South Asian Federation of Obstetrics and Gynaecology. 2024;16(2):126–133. DOI: 10.5005/jp-journals-10006-2401
    Back to article
DOI: https://doi.org/10.5334/gh.1453 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Feb 26, 2025
Accepted on: Jul 23, 2025
Published on: Aug 21, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Cardiovascular diseases,
low and middle-income countries,
hypertensive disorders of pregnancy,
preeclampsia,
women’s health

© 2025 Uma Vasudevan, Preety Rajbangshi, Jane Hirst, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 20 (2025): Issue 1Next article